Keyphrases
7-ketocholesterol
17%
Ablation
12%
Adjusted Hazard Ratio
9%
Alzheimer's Disease
11%
AP39
16%
Arrhythmia
8%
Atrioventricular Delay
8%
Biological Fluids
7%
Biventricular
8%
BV2 Microglia
7%
CAMP Response Element-binding Protein
7%
Cardiac Resynchronization Therapy
100%
Cardiovascular Disease
14%
Cardiovascular Magnetic Resonance
36%
Cardiovascular Mortality
8%
Central Nervous System
12%
Cholesterol
8%
Clinical Outcomes
11%
Conduction System Pacing
7%
Confidence Interval
24%
COVID-19
11%
COVID-19 Pandemic
8%
Defibrillation
10%
Demyelination
17%
Diabetes
11%
Dyssynchrony
11%
Endothelial Cells
18%
European Heart Rhythm Association
11%
Exercise Capacity
7%
Fabry
8%
Fabry Cardiomyopathy
8%
Fabry Disease
12%
Fibrosis
14%
H2S Donors
9%
Hazard Ratio
13%
Heart Failure
15%
Heart Failure Hospitalization
13%
Heart Failure Patients
9%
Heart Tissue
9%
Heme oxygenase-1 (HO-1)
8%
Hemodynamic Effects
12%
High Risk
8%
Hospitalization
8%
Hydrogen Sulfide
33%
Hydrogen Sulfide Donor
18%
Hypertrophic Cardiomyopathy
8%
Implantable Cardioverter-defibrillator Therapy
11%
Implantable Defibrillator
23%
Laser Doppler Flowmetry
7%
Left Ventricular Ejection Fraction
32%
Left Ventricular Function
27%
Left Ventricular Lead
10%
Maternal Low-protein Diet
8%
Meta-analysis
19%
Microvascular Function
9%
Mitochondria
20%
Mitochondrial Dysfunction
13%
Mitochondrial Function
16%
Mitochondrial Targeting
12%
Mitochondrium
20%
Multipoint Pacing
16%
Myocardial Fibrosis
20%
Myocardial Scar
10%
Nanoparticles
9%
Neuroinflammation
9%
Neuroprotectant
7%
Neuroprotective Effect
11%
Non-alcoholic Fatty Liver Disease (NAFLD)
7%
Nonischemic Cardiomyopathy
12%
Oligodendrocyte Precursor Cells
9%
Oxidative Stress
18%
Oxysterol Sulfate
7%
Oxysterols
37%
Patients with Coronary Artery Disease
9%
Patients with Heart Failure
21%
Phencyclidine
8%
Placenta
9%
Polycystic Ovary Syndrome
7%
Preeclampsia
20%
Protein Kinase
7%
Proteomic Study
7%
QRS Duration
26%
Rat Model
18%
Renal Function
7%
Retinal Microvasculature
8%
Scar
14%
Schizophrenia
15%
SH-SY5Y Cells
10%
Signaling Pathway
7%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
20%
Sudden Cardiac Death
36%
Sudden Death
7%
SyncAV
11%
Systematic Meta-analysis
16%
Total Mortality
15%
Transdermal Delivery
11%
Transgenic Mice
11%
Type 2 Diabetes Mellitus (T2DM)
12%
Vascular Endothelial Growth Factor Receptor (VEGFR)
7%
Ventricular Arrhythmia
32%
Medicine and Dentistry
Angiogenesis
5%
Apoplexy
5%
Atrial Fibrillation
9%
Atrial Fibrillation Ablation
5%
Blood Brain Barrier
5%
Cardiac Dysrhythmia
6%
Cardiac Fibrosis
9%
Cardiac Magnetic Resonance Imaging
35%
Cardiac Resynchronization Therapy
97%
Cardiology
8%
Cardiovascular Mortality
5%
Cardiovascular System
15%
Cell Function
5%
Cell Membrane
6%
Cell Signaling Pathway
10%
Central Nervous System
7%
Chronic Kidney Disease
7%
Congestive Heart Failure
57%
Coronary Artery Disease
7%
Coronary Sinus
8%
COVID-19
18%
Defibrillation
7%
Device Therapy
5%
Diseases
12%
Ejection Fraction
5%
Electrocardiogram
6%
Endocardium
7%
Endothelial Cell
6%
Fabry Disease
8%
Fibrosis
5%
Foreign Body Reaction
5%
Gadolinium
6%
Glucose Homeostasis
11%
Hazard Ratio
18%
Heart Left Ventricle Ejection Fraction
22%
Heart Left Ventricle Function
7%
Heart Pacing
7%
Heart Rhythm
11%
Heart Tissue
7%
Heart Ventricle Arrhythmia
20%
Hemodynamic
15%
Homeostasis
5%
Hydrogen Sulfide
15%
Hypertrophic Cardiomyopathy
8%
Implant
5%
Implantable Automatic Defibrillator
29%
Implantable Loop Recorder
5%
In Vitro
13%
Infection
7%
Ischemic Cardiomyopathy
6%
Laser Doppler Flowmetry
7%
Left Bundle Branch Block
9%
Left Ventricular Pacing
7%
Mediator
8%
Meta-Analysis
12%
Mitochondrion
13%
Myocardial Disease
7%
Myocardial Infarction
6%
New York Heart Association Class
10%
Nonischemic Cardiomyopathy
12%
Nutrition
5%
Oligodendrocyte
5%
Oxidative Stress
10%
Patient Referral
8%
Placenta
9%
Polycystic Ovary Syndrome
7%
Pre-Eclampsia
13%
Prevalence
6%
Pulse Rate
8%
QRS Interval
25%
Quality of Life
6%
Randomized Controlled Trial
6%
Reactive Oxygen Species
9%
Remyelination
7%
Risk Stratification
9%
Scar Formation
5%
Severe Acute Respiratory Syndrome
7%
Sudden Cardiac Death
29%
Surgical Anastomosis
5%
Systematic Review
13%
Transgenic Mouse
7%